Since both PDE4 and acetylcholinesterase (AChE) modulators led to improvements in cognitive and memory function, Liu and coworkers designed and synthesized a series of dual PDE4/AChE inhibitors to treat AD. Here, PDE4A is linked to Alzheimer disease.